Medication-assisted treatment (MAT) is the use of medications in combination with counseling and behavioral therapies, which is effective in the treatment of opioid use disorders (OUD) and can help some people to sustain recovery.
There are three drugs approved by the FDA for the treatment of opioid dependence: buprenorphine, methadone, and naltrexone. All three of these treatments have been demonstrated to be safe and effective in combination with counseling and psychosocial support. Everyone who seeks treatment for an OUD should be offered access to all three options. This allows providers to work with patients to select the treatment best suited to an individual’s needs. Due to the chronic nature of OUD, the need for continuing MAT should be re‐evaluated periodically. There is no maximum recommended duration of maintenance treatment and, for some patients, may continue indefinitely.
FDA-approved buprenorphine products approved for the treatment of opioid dependence include:
All medications recommended by the physicians at Eugene and Oleander are approved by the FDA for the treatment of OUD.
- Bunavail (buprenorphine and naloxone) buccal film
- Suboxone (buprenorphine and naloxone) sublingual film for sublingual or buccal use, or sublingual tablet.
- Zubsolv (buprenorphine and naloxone) sublingual tablets
